SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $14,000 | -46.2% | 84 | -54.3% | 0.00% | -50.0% |
| Q3 2020 | $26,000 | -42.2% | 184 | -33.8% | 0.00% | -50.0% |
| Q2 2020 | $45,000 | +55.2% | 278 | +0.7% | 0.00% | +33.3% |
| Q1 2020 | $29,000 | -19.4% | 276 | -1.1% | 0.00% | 0.0% |
| Q4 2019 | $36,000 | +71.4% | 279 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $21,000 | -50.0% | 279 | 0.0% | 0.00% | -60.0% |
| Q2 2019 | $42,000 | +23.5% | 279 | -1.1% | 0.01% | +25.0% |
| Q1 2019 | $34,000 | +47.8% | 282 | +36.2% | 0.00% | +33.3% |
| Q4 2018 | $23,000 | -8.0% | 207 | +3.0% | 0.00% | 0.0% |
| Q3 2018 | $25,000 | 0.0% | 201 | +5.8% | 0.00% | -25.0% |
| Q2 2018 | $25,000 | +78.6% | 190 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $14,000 | -78.8% | 190 | -84.0% | 0.00% | -81.8% |
| Q4 2017 | $66,000 | +22.2% | 1,190 | 0.0% | 0.01% | -8.3% |
| Q3 2017 | $54,000 | – | 1,190 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |